EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Bi-compartmental CSF–serum analysis of NfL and GFAP differentiates central and peripheral pathology in neuroinfectious diseases: A monocentric real-world cohort study

Deborah K Erhart, Badrieh Fazeli, Franziska Bachhuber, Önder Soylu, Makbule Senel, Jan Lewerenz, Markus Otto, Steffen Halbgebauer, Hayrettin Tumani

Neurobiology of Disease · 2026

DOI: 10.1016/j.nbd.2026.107565 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Neurobiology of Disease, 2026. Verfasst von Deborah K Erhart und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany. Electronic address: deborah.erhart@uni-ulm.de. Hauptthemen laut MEDLINE: Glial Fibrillary Acidic Protein, Neurofilament Proteins, Myelitis, Meningitis. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP), established biomarkers of neuroaxonal injury and astroglial pathology, are frequently only assessed in blood, which limits conclusions regarding their origin. Bi-compartmental analyses of CSF and serum may help differentiate central or peripheral origin of biomarker elevation. Moreover, studies on NfL and GFAP in distinct neuroinfectious disease (NID) phenotypes, particularly those based on real-world cohorts, are limited. This retrospective monocentric study analyzed CSF and serum from patients with (meningo-)encephalitis/myelitis (TI+; n = 48), meningitis (TI-; n = 80), (cranial) nerve palsies/polyradiculitis (PND; n = 61), and 113 non-neuroinflammatory/non-neurodegenerative controls. A bi-compartmental model using scatter plots and simple linear regression was applied to assess the origin of blood biomarker levels and discriminate between central and peripheral pathology. CSF and serum NfL and GFAP z-scores were significantly higher in TI+ compared with TI- (CSF-GFAP p < 0.001/sGFAP p = 0.0083; CSF-NfL p = 0.003/sNfL p = 0.0004). TI+ and PND differed only in GFAP levels, which were higher in TI+ (CSF-GFAP p = 0.0049/sGFAP p = 0.003). The overall group effect (p ≤ 0.003) and principal findings remained significant after adjustment for age, sex, QAlb, and time since (symptom) onset to LP. Bi-compartmental analysis revealed simultaneous elevation of CSF and serum NfL in TI+, indicating predominantly central origin, whereas PND demonstrated a shift toward higher sNfL levels suggesting peripheral origin. Higher clinical severity (modified Rankin Scale 3-5) was associated with elevated serum and CSF GFAP and NfL (sGFAP p = 0.012/sNfL p = 0.002; CSF-GFAP p < 0.0001/CSF-NfL p = 0.0001), which also predicted unfavorable outcome at discharge (sGFAP p = 0.006/sNfL p = 0.004; CSF-GFAP p = 0.003/CSF-NfL p = 0.012). NfL and GFAP were associated with brain/myelon involvement in NID, predominantly reflecting central pathology. Despite strong CSF-serum correlations, bi-compartmental approaches provide additional insight into biomarker origin and disease compartment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glial Fibrillary Acidic ProteinNeurofilament ProteinsMyelitisMeningitisHumansMaleFemaleBiomarkersRetrospective StudiesAdultMiddle AgedCohort StudiesAdolescentAgedYoung AdultCranial Nerve Diseases

Stichwörter der Autor:innen

Cerebrospinal fluidEncephalitisGlial fibrillary acidic proteinMeningitisModified Rankin scaleNeurofilament light chainNeuroinfectious diseasesNeuroinfectious diseases of unknown pathogen

Substanzen

Glial Fibrillary Acidic ProteinBiomarkersNeurofilament Proteinsneurofilament protein LGFAP protein, human

Autor:innen und Institutionen

  • Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany. Electronic address: deborah.erhart@uni-ulm.de.
  • Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany. Electronic address: badrieh.fazeli@uni-ulm.de.
  • Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany. Electronic address: franziska.bachhuber@uni-ulm.de.
  • Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany. Electronic address: oender.soylu@uni-ulm.de.
  • Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany. Electronic address: makbule.senel@uni-ulm.de.
  • Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany. Electronic address: jan.lewerenz@uni-ulm.de.

Zitieren

APA

Erhart, D. K., Fazeli, B., Bachhuber, F., Soylu, Ö., Senel, M., Lewerenz, J., Otto, M., Halbgebauer, S., & Tumani, H. (2026). Bi-compartmental CSF–serum analysis of NfL and GFAP differentiates central and peripheral pathology in neuroinfectious diseases: A monocentric real-world cohort study. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2026.107565

Vancouver

Erhart DK, Fazeli B, Bachhuber F, Soylu Ö, Senel M, Lewerenz J, et al. Bi-compartmental CSF–serum analysis of NfL and GFAP differentiates central and peripheral pathology in neuroinfectious diseases: A monocentric real-world cohort study. Neurobiology of Disease. 2026. doi:10.1016/j.nbd.2026.107565

BibTeX
@article{Erhart2026,
  author = {Erhart, Deborah K and Fazeli, Badrieh and Bachhuber, Franziska and Soylu, Önder and Senel, Makbule and Lewerenz, Jan and Otto, Markus and Halbgebauer, Steffen and Tumani, Hayrettin},
  title = {Bi-compartmental CSF–serum analysis of NfL and GFAP differentiates central and peripheral pathology in neuroinfectious diseases: A monocentric real-world cohort study},
  journal = {Neurobiology of Disease},
  year = {2026},
  doi = {10.1016/j.nbd.2026.107565}
}
Kostenlos starten →